Prostate cancer immunotherapy improves overall survival – ModernMedicine

The autologous cellular immunotherapy sipuleucel-T (Provenge) appears to demonstrate an overall survival benefit in patients with advanced prostate cancer, according to two studies presented at the AUA annual meeting in Atlanta. An exploratory …

Posted in Uncategorized